Immune Activation Repurposed for Developing Hepatitis C Therapy
Share
Follow Us
The Editors at Hepatitis Central
February 17, 2011
Medical chemists from the UK are working on an oral Hepatitis C drug that works by activating a protein in the immune system.
New hepatitis C drug
14 February 2011
Scientists in the UK have developed a compound to combat the hepatitis C virus that could be taken as a pill.
David Pryde and his team from Pfizer Global Research and Development, Sandwich, have made new compounds to activate a protein in the immune system called TLR7 – toll-like receptor 7 – which fights the infection. Toll-like receptors identify foreign DNA, such as a virus, and produce proteins that inhibit the virus’ replication.
Continue reading this entire article:
http://www.rsc.org/chemistryworld/News/2011/February/14021101.asp
